FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1985635303> ?p ?o ?g. }

• W1985635303 endingPage "346" @default.
• W1985635303 startingPage "341" @default.
• W1985635303 abstract "The metabolic origins of equine hyperlipaemia were investigated by analysing the concentration and composition of plasma lipoproteins in 18 ponies with the condition. The mean concentrations of cholesterol, triglyceride and very low density lipoproteins (VLDL) were increased by 4-, 52- and 19-fold, respectively, compared with a control group of 18 healthy ponies. These increases were due to the appearance of a buoyant VLDL fraction (VLDL1) not present in healthy ponies. The mean diameter of VLDL1 particles was 44% greater than control VLDL, and the particles were enriched in triglyceride and free cholesterol and depleted of cholesteryl esters, phospholipid and protein. The apolipoprotein (apo) B-100 content of VLDL1 was reduced and the ratio of apoB-100 to apoB-48 particles was 1:1, compared with 2:1 in control VLDL. The VLDL1 was also enriched in apoE, but had normal complements of apoC-II and apoC-III. The conventional VLDL (called VLDL2), LDL and HDL fractions were moderately enriched with triglyceride, and HDL contained increased amounts of apoE, apoC-II and apoC-III. The activities of lipoprotein lipase and hepatic lipase, the enzymes responsible for the catabolism of VLDL and their remnants, were increased by 2- and 3-fold, respectively, in response to the increased concentrations of their substrates. The composition of VLDL1 suggested that the liver was maximising the secretion of triglyceride by producing larger number of VLDL particles that accommodated a greater mass of triglyceride by having apoB-48 rather than apoB-100 as their structural protein. Plasma free fatty acid (FFA) concentrations were elevated in 17 of the 18 ponies, suggesting that increased FFA flux might be the stimulus for hepatic triglyceride synthesis and VLDL secretion. We conclude that overproduction, rather than defective catabolism, of VLDL was the cause of the hyperlipidaemia and that lipid lowering agents which reduce VLDL synthesis, by decreasing adipose lipolysis and FFA flux, are candidates for the management of hyperlipaemia." @default.
• W1985635303 created "2016-06-24" @default.
• W1985635303 creator A5037853560 @default.
• W1985635303 creator A5040513686 @default.
• W1985635303 creator A5048047555 @default.
• W1985635303 creator A5049269746 @default.
• W1985635303 creator A5050194559 @default.
• W1985635303 date "1992-09-01" @default.
• W1985635303 modified "2023-10-14" @default.
• W1985635303 title "Plasma lipids, lipoproteins and post-heparin lipases in ponies with hyperlipaemia" @default.
• W1985635303 cites W1029596508 @default.
• W1985635303 cites W1468081261 @default.
• W1985635303 cites W1966927487 @default.
• W1985635303 cites W1983843373 @default.
• W1985635303 cites W1988800978 @default.
• W1985635303 cites W1998841005 @default.
• W1985635303 cites W2001752924 @default.
• W1985635303 cites W2006092568 @default.
• W1985635303 cites W2009410609 @default.
• W1985635303 cites W2019178980 @default.
• W1985635303 cites W2037507091 @default.
• W1985635303 cites W2045948526 @default.
• W1985635303 cites W2066644955 @default.
• W1985635303 cites W2073336522 @default.
• W1985635303 cites W2080478929 @default.
• W1985635303 cites W2081394180 @default.
• W1985635303 cites W2091096933 @default.
• W1985635303 cites W2100680258 @default.
• W1985635303 cites W2102131116 @default.
• W1985635303 cites W2105190993 @default.
• W1985635303 cites W2111496727 @default.
• W1985635303 cites W2135503869 @default.
• W1985635303 cites W2160042484 @default.
• W1985635303 cites W2164468903 @default.
• W1985635303 cites W2169709704 @default.
• W1985635303 cites W2181656195 @default.
• W1985635303 cites W2253996060 @default.
• W1985635303 cites W2327887667 @default.
• W1985635303 cites W2419519580 @default.
• W1985635303 cites W2963069031 @default.
• W1985635303 cites W4232046015 @default.
• W1985635303 cites W4234215706 @default.
• W1985635303 doi "https://doi.org/10.1111/j.2042-3306.1992.tb02852.x" @default.
• W1985635303 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1396507" @default.
• W1985635303 hasPublicationYear "1992" @default.
• W1985635303 type Work @default.
• W1985635303 sameAs 1985635303 @default.
• W1985635303 citedByCount "52" @default.
• W1985635303 countsByYear W19856353032012 @default.
• W1985635303 countsByYear W19856353032013 @default.
• W1985635303 countsByYear W19856353032014 @default.
• W1985635303 countsByYear W19856353032015 @default.
• W1985635303 countsByYear W19856353032017 @default.
• W1985635303 countsByYear W19856353032018 @default.
• W1985635303 countsByYear W19856353032019 @default.
• W1985635303 countsByYear W19856353032020 @default.
• W1985635303 countsByYear W19856353032021 @default.
• W1985635303 countsByYear W19856353032022 @default.
• W1985635303 crossrefType "journal-article" @default.
• W1985635303 hasAuthorship W1985635303A5037853560 @default.
• W1985635303 hasAuthorship W1985635303A5040513686 @default.
• W1985635303 hasAuthorship W1985635303A5048047555 @default.
• W1985635303 hasAuthorship W1985635303A5049269746 @default.
• W1985635303 hasAuthorship W1985635303A5050194559 @default.
• W1985635303 hasConcept C126322002 @default.
• W1985635303 hasConcept C134018914 @default.
• W1985635303 hasConcept C140985366 @default.
• W1985635303 hasConcept C171089720 @default.
• W1985635303 hasConcept C181199279 @default.
• W1985635303 hasConcept C185592680 @default.
• W1985635303 hasConcept C2778163477 @default.
• W1985635303 hasConcept C2778913445 @default.
• W1985635303 hasConcept C2780072125 @default.
• W1985635303 hasConcept C2780213950 @default.
• W1985635303 hasConcept C55493867 @default.
• W1985635303 hasConcept C62746215 @default.
• W1985635303 hasConcept C71924100 @default.
• W1985635303 hasConcept C8004288 @default.
• W1985635303 hasConcept C8243546 @default.
• W1985635303 hasConcept C86803240 @default.
• W1985635303 hasConcept C94879076 @default.
• W1985635303 hasConceptScore W1985635303C126322002 @default.
• W1985635303 hasConceptScore W1985635303C134018914 @default.
• W1985635303 hasConceptScore W1985635303C140985366 @default.
• W1985635303 hasConceptScore W1985635303C171089720 @default.
• W1985635303 hasConceptScore W1985635303C181199279 @default.
• W1985635303 hasConceptScore W1985635303C185592680 @default.
• W1985635303 hasConceptScore W1985635303C2778163477 @default.
• W1985635303 hasConceptScore W1985635303C2778913445 @default.
• W1985635303 hasConceptScore W1985635303C2780072125 @default.
• W1985635303 hasConceptScore W1985635303C2780213950 @default.
• W1985635303 hasConceptScore W1985635303C55493867 @default.
• W1985635303 hasConceptScore W1985635303C62746215 @default.
• W1985635303 hasConceptScore W1985635303C71924100 @default.
• W1985635303 hasConceptScore W1985635303C8004288 @default.
• W1985635303 hasConceptScore W1985635303C8243546 @default.
• W1985635303 hasConceptScore W1985635303C86803240 @default.
• W1985635303 hasConceptScore W1985635303C94879076 @default.

• next